Literature DB >> 34010232

MDRO transmission in acute hospitals during the COVID-19 pandemic.

Louisa Sun Jin1, Dale Fisher.   

Abstract

PURPOSE OF REVIEW: The coronavirus disease (COVID-19) pandemic has resulted in necessary modifications of infection control policies and practices in acute healthcare facilities globally. This is often accompanied by infrastructure modifications, ward redesignations, as well as healthcare staff redeployments and changes to infection prevention and control (IPC) practices. We review the potential for both negative and positive impacts these major changes can have on nosocomial transmission of multidrug-resistant organisms (MDROs). RECENT
FINDINGS: Healthcare facilities around the world have report outbreaks of MDROs during the COVID-19 pandemic. In contrast some centres have reported a decrease in baseline rates due to a number of possible factors.
SUMMARY: While implementing crucial preventive measures for COVID-19, is it important to consider any collateral effects of changes in IPC and antimicrobial stewardship program (ASP) practices. The disruption caused to IPC and ASP practices during the pandemic are likely to see a counter intuitive increase in transmission of MDROs.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34010232     DOI: 10.1097/QCO.0000000000000735

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  4 in total

1.  Antimicrobial Stewardship in the Covid-19 Pandemic.

Authors:  Sergio Venturini; Manuela Avolio; Sara Fossati; Astrid Callegari; Rita De Rosa; Barbara Basso; Chiara Zanusso; Daniele Orso; Francesco Cugini; Massimo Crapis
Journal:  Hosp Pharm       Date:  2022-02-10

2.  Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic.

Authors:  Vincent Chi-Chung Cheng; Shuk-Ching Wong; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Pui-Hing Chau; Albert Ka-Wing Au; Kelvin Hei-Yeung Chiu; Xin Li; Patrick Ip; Vivien Wai-Man Chuang; David Christopher Lung; Cindy Wing-Sze Tse; Rodney Allan Lee; Kitty Sau-Chun Fung; Wing-Kin To; Raymond Wai-Man Lai; Tak-Lun Que; Janice Yee-Chi Lo; Kwok-Yung Yuen
Journal:  Antibiotics (Basel)       Date:  2022-05-31

3.  COVID-19 and C. auris: A Case-Control Study from a Tertiary Care Center in Lebanon.

Authors:  Fatima Allaw; Sara F Haddad; Nabih Habib; Pamela Moukarzel; Nour Sabiha Naji; Zeina A Kanafani; Ahmad Ibrahim; Nada Kara Zahreddine; Nikolaos Spernovasilis; Garyphallia Poulakou; Souha S Kanj
Journal:  Microorganisms       Date:  2022-05-11

4.  Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: a multicenter study.

Authors:  Hyo-Ju Son; Tark Kim; Eunjung Lee; Se Yoon Park; Shinae Yu; Hyo-Lim Hong; Min-Chul Kim; Sun In Hong; Seongman Bae; Min Jae Kim; Sung-Han Kim; Ji Hyun Yun; Kyeong Min Jo; Yu-Mi Lee; Seungjae Lee; Jung Wan Park; Min Hyok Jeon; Tae Hyong Kim; Eun Ju Choo
Journal:  Am J Infect Control       Date:  2021-06-16       Impact factor: 2.918

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.